Asit Parikh, a director at $PHAT, bought 10,000 shares of the company on 03-13-2025 for an estimated $44,200. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 13.2%. Following this trade, they now own 85,500 shares of this class of $PHAT stock.
$PHAT Insider Trading Activity
$PHAT insiders have traded $PHAT stock on the open market 8 times in the past 6 months. Of those trades, 3 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $PHAT stock by insiders over the last 6 months:
- TERRIE CURRAN (President and Chief Executive) sold 19,109 shares for an estimated $125,884
- ASIT PARIKH has made 2 purchases buying 20,000 shares for an estimated $125,448 and 0 sales.
- FRANK KARBE purchased 12,500 shares for an estimated $99,083
- AZMI NABULSI (Chief Operating Officer) has made 0 purchases and 2 sales selling 9,004 shares for an estimated $60,900.
- MOLLY HENDERSON (CFO and CBO) has made 0 purchases and 2 sales selling 7,874 shares for an estimated $53,698.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PHAT Hedge Fund Activity
We have seen 92 institutional investors add shares of $PHAT stock to their portfolio, and 55 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PORTOLAN CAPITAL MANAGEMENT, LLC removed 1,699,918 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $13,803,334
- GILDER GAGNON HOWE & CO LLC removed 1,581,273 shares (-97.4%) from their portfolio in Q4 2024, for an estimated $12,839,936
- WOODLINE PARTNERS LP removed 1,571,720 shares (-61.1%) from their portfolio in Q4 2024, for an estimated $12,762,366
- TAKEDA PHARMACEUTICAL CO LTD removed 1,557,063 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $28,151,699
- ORBIMED ADVISORS LLC removed 1,449,073 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $11,766,472
- FEDERATED HERMES, INC. removed 1,403,638 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $11,397,540
- WASATCH ADVISORS LP added 1,311,986 shares (+531.3%) to their portfolio in Q4 2024, for an estimated $10,653,326
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PHAT Analyst Ratings
Wall Street analysts have issued reports on $PHAT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Craig-Hallum issued a "Buy" rating on 03/07/2025
To track analyst ratings and price targets for $PHAT, check out Quiver Quantitative's $PHAT forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
